Correlation Between Dyadic International and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Enliven Therapeutics, you can compare the effects of market volatilities on Dyadic International and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Enliven Therapeutics.
Diversification Opportunities for Dyadic International and Enliven Therapeutics
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dyadic and Enliven is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and Enliven Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to generate 3.26 times less return on investment than Enliven Therapeutics. But when comparing it to its historical volatility, Dyadic International is 1.18 times less risky than Enliven Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1,159 in Enliven Therapeutics on August 27, 2024 and sell it today you would earn a total of 1,295 from holding Enliven Therapeutics or generate 111.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyadic International vs. Enliven Therapeutics
Performance |
| Timeline |
| Dyadic International |
| Enliven Therapeutics |
Dyadic International and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyadic International and Enliven Therapeutics
The main advantage of trading using opposite Dyadic International and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Dyadic International vs. Werewolf Therapeutics | Dyadic International vs. Edgewise Therapeutics | Dyadic International vs. Celcuity LLC | Dyadic International vs. C4 Therapeutics |
| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |